Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations.
Ciurea SO, Chilkulwar A, Saliba RM, Chen J, Rondon G, Patel KP, Khogeer H, Shah AR, Randolph BV, Perez JMR, Popat U, Hosing CM, Bashir Q, Mehta R, Al-Atrash G, Im J, Khouri IF, Kebriaei P, Champlin RE.
Ciurea SO, et al. Among authors: khogeer h.
Blood. 2018 Jun 28;131(26):2989-2992. doi: 10.1182/blood-2018-02-832360. Epub 2018 May 16.
Blood. 2018.
PMID: 29769261
Free PMC article.
No abstract available.